Trials / Conditions / Solid Tumors Refractory to Standard Therapy
Solid Tumors Refractory to Standard Therapy
4 registered clinical trials studyying Solid Tumors Refractory to Standard Therapy — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors NCT06911333 | Avelos Therapeutics Inc. | Phase 1 / Phase 2 |
| Recruiting | A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. NCT06883539 | LaunXP Biomedical Co., Ltd. | Phase 1 |
| Recruiting | Interventional Study to Evaluate the Combination of Palbociclib + Sunitinib as a Treatment for Advanced Solid NCT06940349 | Rabin Medical Center | Phase 1 / Phase 2 |
| Completed | Kanglaite Injection Phase I Study NCT00031031 | KangLaiTe USA | Phase 1 |